12/19/2024 6:00 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2024 3:12 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
12/09/2024 6:05 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/26/2024 3:08 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/22/2024 3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2024 7:10 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/13/2024 4:15 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
|
11/12/2024 3:52 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
11/08/2024 4:31 PM | Hudson Bay Capital Management LP (Filed by) NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024 3:46 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:15 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:19 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
10/16/2024 3:27 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 3:19 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFM14A | |
09/25/2024 4:17 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form PREM14A | |
09/20/2024 7:08 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 7:08 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
07/29/2024 3:25 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 6:18 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 424B4 | |
07/26/2024 4:19 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form POS EX | |
07/25/2024 11:15 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form EFFECT | |
07/24/2024 7:49 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
07/12/2024 5:21 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
07/11/2024 7:50 AM | NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject)
| Form FWP | |
07/11/2024 7:45 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 3:05 PM | NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject)
| Form FWP | |
07/10/2024 8:30 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form S-1/A | |
06/28/2024 3:21 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 424B3 | |
06/28/2024 2:19 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
06/27/2024 11:15 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form EFFECT | |
06/21/2024 4:26 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
06/20/2024 4:12 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
06/14/2024 7:47 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:30 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2024 3:50 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2024 3:43 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K/A | |
05/30/2024 8:24 PM | NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) WU MIJIA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 8:27 PM | NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) Sit Swan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 8:29 PM | Freiman Paul E. (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 8:31 PM | Garlikov Julie (Reporting) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 8:17 PM | NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) Zheng Yongxiang (Reporting) Zheng Yongxiang (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
This Indicator called BOTH NVDA rallies (Ad) Rarely would I label something as “the best”
But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock.
Except, it’s not another tech stock like Nvidia.
But rather a stock hiding in broad daylight…
So, if you’d like to see what this stock is…
Click this link here. |
05/30/2024 8:22 PM | NovaBay Pharmaceuticals, Inc. (Issuer) NovaBay Pharmaceuticals (Issuer) Zheng Yenyou (Reporting) Zheng Yenyou (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:27 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/22/2024 5:04 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2024 4:21 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 8:15 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form ARS | |
04/18/2024 8:00 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024 8:06 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form DEFA14A | |
04/08/2024 3:15 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form PRE 14A | |
04/05/2024 11:27 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/29/2024 10:00 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 10-K/A | |
03/26/2024 3:14 PM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 6:30 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 6:30 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/14/2024 7:30 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 1:52 PM | ARMISTICE CAPITAL, LLC (Filed by) NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024 10:52 AM | Hudson Bay Capital Management LP (Filed by) NovaBay Pharmaceuticals, Inc. (Subject) NovaBay Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/10/2024 7:00 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 10:50 AM | NovaBay Pharmaceuticals, Inc. (Filer) NovaBay Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |